Jörg Kneubühler

Chief Executive Officer, Galenica Santé at Vifor Pharma AG

Jörg Kneubühler

Jörg Kneubühler

Chief Executive Officer, Galenica Santé at Vifor Pharma AG

Biography

Presently, Jörg Kneubühler holds the position of Chairman of Galenica AG. In the past he occupied the position of CFO, Head-Finance & Controlling at Vifor Pharma AG and Head-Finance & Administration at Vifor Pharma Management AG (a subsidiary of Vifor Pharma AG). He received a doctorate from the University of Bern.

Overview
RelSci Relationships

115

Number of Boards

3

Birthday

1960

Age

59

Contact Data
Trying to get in touch with Jörg Kneubühler? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jörg Kneubühler likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & President at Neue Zürcher Zeitung AG

Relationship likelihood: Strong

Chief Executive Officer at OM Pharma SA

Relationship likelihood: Strong

Director & Head-Investor Relations at Vifor Pharma AG

Relationship likelihood: Strong

Chief Executive Officer, Vifor Pharma at Vifor Pharma AG

Relationship likelihood: Strong

Secretary & Director at Vifor Pharma AG

Relationship likelihood: Strong

Chief Executive Officer at Galenica AG

Relationship likelihood: Strong

Chief Medical Officer at Vifor Pharma AG

Relationship likelihood: Strong

Professional at Galenica AG

Relationship likelihood: Strong

Treasurer at European Society of Hypertension

Relationship likelihood: Strong

Chief Financial Officer & Head-Investor Relations at Galenica AG

Relationship likelihood: Strong

Paths to Jörg Kneubühler
Potential Connections via
Relationship Science
You
Jörg Kneubühler
Chief Executive Officer, Galenica Santé at Vifor Pharma AG
Career History
Chief Executive Officer, Galenica Santé
2002 - Current

Vifor Pharma AG, formerly Galenica AG, is a global pharmaceuticals company, which engages in the research, development, production, and marketing of pharmaceutical products in iron deficiency, nephrology, and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures, and markets pharmaceutical products for precision patient care. The Group consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Head-Finance & Administration
2002 - Prior

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. The firm also offers a diversified portfolio of prescription medicines as well as over-the-counter products. It operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription (OTC, overthe-counter) products. The company was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

Professional
Prior

Swatch Group is an international group active in the design, manufacture and sale of finished watches, jewelry, watch movements and components. Swatch Group supplies nearly all components required by its nineteen watch brands, and Swatch Group companies supply movements and components to third-party watchmakers in Switzerland and around the world. Please be sure to visit our brands' websites to learn more about their fantastic products. Swatch Group is also a key player in the manufacture and sale of electronic systems used in watchmaking and other industries. Swatch Group employs more than 29 700 persons in over 50 countries. Gross sales in 2012 amounted to 8.143 billion Swiss francs (2011: 7.143), net profit to 1.608 billion Swiss francs (2011: 1.276 billion)

Boards & Committees
Chairman
2017 - Current

Galenica AG provides health, beauty, and wellbeing products and services. It operates through Health & Beauty, and Services segments. The Health & Beauty segment comprises the business sectors Products & Brands and Retail, which together with the pharmacy network in Switzerland. The Services segment comprises the logistics companies and HCI Solutions, which support players in the Swiss healthcare market with solutions from a single source. The company was founded on February 13, 2017 and is headquartered in Bern, Switzerland.

Member, Corporate Executive Committee
2002 - Current

Vifor Pharma AG, formerly Galenica AG, is a global pharmaceuticals company, which engages in the research, development, production, and marketing of pharmaceutical products in iron deficiency, nephrology, and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures, and markets pharmaceutical products for precision patient care. The Group consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Director
2008 - Prior

Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jörg Kneubühler. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jörg Kneubühler's profile does not indicate a business or promotional relationship of any kind between RelSci and Jörg Kneubühler.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/jorg-kneubuhler-3854206
  • https://relationshipscience.com/person/jorg-kneubuhler-3854206